Aurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference
VICTORIA, British Columbia-- Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX:AUP) today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate overview of the Company at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference, taking place September 11th-13th at the Lotte New York Palace Hotel in New York City. The presentation will also be available via webcast at the link listed below.
Aurinia Presentation Details
|
Date: |
Monday, September 12th, 2016 |
|
|
Time: |
10:00 a.m. Eastern time |
|
|
Location: |
Lotte New York Palace Hotel, Louis Room (4th floor) |
|
|
Webcast: |
About Aurinia
Aurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering from
serious diseases with a high unmet medical need. The company is
headquartered in Victoria, BC and focuses its development efforts
globally.
Visit www.auriniapharma.com for more information.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160907005670/en/
Investor & Media Contact:
Celia Economides
Associate
VP, Investor Relations
ceconomides@auriniapharma.com
Source: Aurinia Pharmaceuticals Inc.
Released September 7, 2016
